Astrana Health, Inc.

What they do

{ "headline": "Astrana Health, Inc. is a physician-centric, technology-enabled healthcare company that organizes independent physicians into value-based care networks, primarily in California.", "what_they_do": "Astrana operates through three segments: Care Partners (medical groups and IPAs), Care Delivery (physician and ancillary services), and Care Enablement (management services, technology, and risk-bearing contracts). The company contracts with payers, including Medicare Advantage plans and government programs, to manage patient populations and share in savings or risk.", "revenue_drivers": [ { "name": "Care Partners", "detail": "Largest segment, $932.8M in Q2 2026 (48% YoY growth), representing medical group and IPA revenues from capitation and shared savings." }, { "name": "Care Delivery", "detail": "Includes physician and ancillary services; $74.7M in Q2 2026, up 95% YoY, driven by expanded clinical capabilities and acquisitions." }, { "name": "Care Enablement", "detail": "Management services and technology platform; $85.6M in Q2 2026, up 109% YoY, reflecting growth in management contracts and value-based care arrangements." } ], "recent_performance": "For Q2 2026, total revenue was $972.5M, up 49% YoY; net income attributable to Astrana was $19.7M, up 109%; diluted EPS was $0.40. Adjusted EBITDA rose 43% to $68.9M. For the six months ended June 30, 2026, revenue was $1,937.6M, net income attributable was $34.2M, and operating cash flow was $100.8M. Revenue has grown from $773.9M in 2021 to $3.18B in 2025, though net income declined to $24M in 2025.", "strategy": "Management emphasizes scaling its 'physician-centric, AI-native healthcare operating system,' expanding Medicare Advantage footprint into new states (Hawaii, Texas) and adding professional-risk lives. Leadership additions (Daniel Rothman, Vishal Gupta) aim to strengthen enterprise transformation and physician enterprise operations. The company is reinvesting first-half outperformance into growth initiatives to enhance long-term earnings power.", "risks": [ { "title": "Declining net income margin", "detail": "Net income fell from $50M in 2024 to $24M in 2025 despite revenue growth, indicating margin compression." }, { "title": "High leverage", "detail": "Long-term debt of $882.6M against equity of $830.2M as of June 30, 2026, increasing financial risk." }, { "title": "Regulatory and government program risk", "detail": "Dependence on Medicare Advantage and ACO programs exposes the company to CMS policy changes and shared savings variability." }, { "title": "Integration and acquisition risk", "detail": "Rapid growth through acquisitions (e.g., Prospect) and new market entries may strain operations and management resources." } ], "outlook": "Management raised adjusted EBITDA guidance for 2026, citing strong demand and cash flow generation. They plan to continue expanding value-based care arrangements and AI-native platform adoption. Growth is expected to be driven by new Medicare Advantage agreements and provider/payer demand." ], "key_facts": [ { "label": "Ticker", "value": "NASDAQ: ASTH" }, { "label": "FY2025 revenue", "value": "$3.18B" }, { "label": "Q2 2026 revenue", "value": "$972.5M, up 49% YoY" }, { "label": "Q2 2026 adjusted EBITDA", "value": "$68.9M, up 43% YoY" }, { "label": "Cash and equivalents", "value": "$400.8M as of 2026-06-30" } ] }